February 2019 
In 2018, industry revenue grew 3.5% over 2017. Results were mixed among the largest companies as some stumbled operationally while others overperformed, due in part to early adoption of technology and entry into high-growth segments.
A roundup of the companies and products that received clearances in 2018. The spine market is most significantly represented, and the majority of companies (71%) are located in the U.S. 


In trauma, new products like Femoral Recon Nails gained traction supported by a growing market. Knee sales were impacted by competitive pressure in the U.S. We provide estimates for segment sales and growth, as well as orthopedic product sales by geographic region.
The company claims market leadership in sports medicine hips, with room to grow in knees and shoulders. Provided are ORTHOWORLD estimates for segment sales and growth. 

OMTEC 2019 Agenda 

6 Orthopedic Coatings Sessions | 4 Additive Manufacturing Sessions | EU MDR Workshop
Automation, Artificial Intelligence, Augmented Reality

Must-attend events:
Keynotes: State and Future of the Orthopedic Industry:  Device Executive  and  Surgeon Perspective

Workshops: EU Medical Device Regulations, Forecasting and Inventory Optimization for your Supply Chain

Sessions:  Product Lifecycle Management and Team Development 

The company's proprietary Cohere Porous polyetheretherketone (PEEK) implant demonstrated clear benefits in promoting improved outcomes in Anterior Cervical Discectomy and Fusion.  
Austria-based BRI.Tech is the developer of a patented novel biocompatible and bioresorbable metal composition. Biotec, located in Finland, is developing projects that include fiber-reinforced biopolymer composite materials, and this transaction will add another material option to its portfolio.
This represents the largest system that Nextremity has brought to market, to date. 
The study is a prospective, postmarket evaluation of the safety and performance of Fortlink-C, -TS, and -L interbody fusion systems made with TETRAfuse 3D-printed polymer material.

InSet Glenoid technology demonstrated long-term efficacy and safety in total shoulder replacement surgery to reconstruct deficient, arthritic gleniod bone.